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Abstract 
Endocannabinoids (eCBs) and acylethanolamides (AEs) have lately received more attention 
due to their neuroprotective functions in neurological disorders. Here we analyze the 
alterations induced by perinatal asphyxia (PA) in the main metabolic enzymes and 
receptors of the eCBs/AEs in the dorsal striatum of rats. To induce PA, we used a model 
developed by Bjelke et al. (1991). Immunohistochemical techniques were carried out to 
determine the expression of neuronal and glial markers (NeuN and GFAP), eCBs/AEs 
synthesis and degradation enzymes (DAGLα, NAPE-PLD and FAAH) and their receptors 
(CB1 and PPARα). We found a decrease in NAPE-PLD and PPARα expression. Since 
NAPE-PLD and PPARα take part in the production and reception of biochemical actions of 
AEs, such as oleoylethanolamide, these results may suggest that PA plays a key role in the 
regulation of this system. These data agree with previous results obtained in the 
hippocampus and encourage us to develop further studies using AEs as potential 
neuroprotective compounds. 
 
Abbreviations 
2-AG: 2-arachidonoyglycerol 
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1. Introduction 
The consequences of perinatal asphyxia (PA) lead to metabolic dysfunctions [1] and the 
central nervous system (CNS) is especially vulnerable to the oxidative damage caused by 
PA [2]. It has been reported that 25% of those newborns who survive PA develop different 
neurological disorders [3]. 
In the present work we employed a model developed by Bjelke et al. [4] that has been 
broadly employed [5-11]. Previous results show that PA can cause significant damage in 
different areas of the CNS, among them the striatum [4-6,10,11], such as astrogliosis, 
decreased phosphorylation of high and medium molecular weight neurofilaments, and 
synaptic alterations [6-8]. 
The endogenous cannabinoid system (ECS) is comprised of cannabinoid receptors, 
endocannabinoids (eCBs) and enzymes responsible for these lipids’ synthesis, transport 
and inactivation [12]. The ECS is quite known for its regulation over different 
neurophysiological processes through the activation of cannabinoid receptors 1 and 2 
(CB1, CB2) [12-14]. 
CB1 is a protein-G coupled receptor highly expressed in the CNS [15,16]. eCBs are divided 
into two groups that present specific structures, acylethanolamides (AEs) and 
monoacylglycerols (MAGs) [12,17]. AEs are synthesized from glycerophospholipids in a 
reaction comprising 2 steps: 1) N-acyl-phosphatidylethanolamine (NAPE) is synthesized 
trough the action of the N-acyl transferase; 2 ) the AE is released from NAPE by the 
NAPE‐hydrolyzing phospholipase D (NAPE‐PLD). AEs are degraded by the fatty acid 
amide hydrolase (FAAH) [12,18-20]. Concerning MAGs, the main synthetic enzyme 
involved in its biosynthetic pathway is the diacylglycerol lipase (DAGL), while they are 
inactivated through the action of the MAG lipase (MAGL) [12,19,20]. 
Palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) are AEs that share 
biosynthetic and degradative pathways with the acylethanolamide AEA, but do not bind to 
CB1 or CB2 [21,22]. Nevertheless, they present neuromodulatory properties as endogenous 
agonists of peroxisome proliferator-activated receptor alpha (PPARα). PPARs are ligand-
activated transcription factors [23] that play an important neuroprotective role in several 
diseases [24]. 
Although it has been previously demonstrated that the ECS plays a neuroprotective role in 
models of neonatal and adult cerebral ischemia [13,25,26], this effect has not yet been 
tested in the PA model developed by Bjelke et al. [4]. In former works, OEA and PEA have 
been shown to present neuroprotective effects in adult cerebral ischemia [27,28], but they 
have not been tested in neonatal hypoxia-ischemia models. Consequently, our aim was to 
analyze how the eCBs/AEs signaling system is affected in the rodent model of PA 
developed by Bjelke et al. [4]. We studied the expression of DAGLα, NAPE-PLD, CB1, 
PPARα and FAAH in the dorsal striatum of control (CTL), cesarean delivery (C+) and 
asphyctic (PA) 30-day-old rats. 
2. Material and methods 
2.1. Ethics statements 
Previously approved procedures (Institutional Animal Care and Use Committee at the 
University of Buenos Aires and the Committee on Ethics of the Hospital R. U. de Málaga) 
were carried out under strict adherence to the European Directive 2010/63/EU on the 
protection of animals used for experimentation, as well as with Spanish regulations (RD 
53/2013 and 178/2004). All efforts were made to reduce the number of animals used and to 
minimize their suffering. 
2.2. Animals, cesarean section and perinatal asphyxia procedures 
Animal procedures and a detailed description of the PA model employed can be found in 
Supplementary Material (sections 1 and 2). 
2.3. Sample processing and immunohistochemistry 
Methods used are described in sections 3 and 4 of the Supplementary Material. 
2.4. Immunostaining quantification and NeuN stereological analysis 
We studied five to seven coronal sections acquired from 5-6 animals per group. These 
sections were obtained from Bregma levels 1.2 mm to 0.2 mm (dorsal striatum) [29]. Both 
densitometry (NeuN, NAPE-PLD, FAAH, DAGLα, and CB1) and cell counting (GFAP 
and PPARα) were performed using Image J 1.38X (NIH, USA). Stereological analysis of 
NeuN-positive cells was performed as previously described [5]. Detailed descriptions can 
be found in Supplementary Material (sections 5 and 6). 
2.5. Statistical analysis 
Data were examined by one-way ANOVA tests followed by post-hoc tests (Bonferroni’s 
correction) using the SSPS 15.0 (SPSS Inc., Chicago, IL, USA). A probability was 
considered as significant ≤ 5% (two-tailed). 
3. Results 
3.1. NeuN and GFAP immunostaining in dorsal striatum 
The number of total NeuN-positive cells in dorsal striatum did not differ between groups 
(F(2, 15) = 2.01, p = n.s.; Fig.1). However, the PA group showed an increment of the number 
of GFAP-positive cells compared to CTL and C+ groups (F(2, 15) = 5.75, p = 0.01; Post-hoc 
comparisons: p< 0.05; Fig.1). 
3.2. Immunohistochemical expression of DAGLα and NAPE-PLD 
The C+ group showed a higher mean optical density for the DAGLα immunostaining than 
CTL and PA groups (F(2, 14) = 7.13, p< 0.01; Post-hoc comparisons: p< 0.05; Fig.2). 
Regarding NAPE-PLD immunostaining, the PA group displayed a lower mean optical 
density than the other two groups. (F(2, 15) = 6.73, p< 0.01; Post-hoc comparisons: p< 0.05; 
Fig. 2). 
3.3. Immunohistochemical expression of CB1, PPARα and FAAH. 
In both striatal subregions (lateral and medial), the PA group showed higher mean optical 
densities for the CB1 immunostaining compared to CTL group (Lateral: F(2, 15) = 4.50, p< 
0.05; Medial: F(2, 15) = 5.40, p< 0.05; Post-hoc comparisons: p< 0.05; Fig.3). No differences 
were found between C+ and PA and between CTL and C+ groups (p=n.s.; Fig 3). 
Regarding PPARα, the PA group displayed a lower number of PPARα-positive nuclei than 
the other two groups (F(2, 15) = 7.41, p< 0.01;. Post-hoc comparisons: p< 0.05 vs. CTL and 
p< 0.01 vs. C+; Fig. 3). Finally, the levels of FAAH were not different between groups (F(2, 
15) < 1; Fig. 4). 
4. Discussion 
A growing evidence indicates that modulation of the ECS has neuroprotective effects in 
hypoxia-ischemia [13,25,26]. Regarding AEs that do not bind to CB receptors, it has been 
demonstrated that OEA administration before ischemic brain injury induces an increase in 
PPARα expression and reduces infarct volume and brain edema in mice [28]. In the present 
work, we have found a reduction in NAPE-PLD levels along with a reduced expression of 
the OEA receptor, PPARα, which may suggest that the potential neuroprotective role of this 
system is impaired. 
4.1. Asphyctic rats show astrogliosis in the striatum with the absence of neuronal loss  
The striatum is one of the most affected areas after a hypoxic-ischemic event [30]. Kruse et 
al. [31] demonstrated that organotypic striatum cultures exposed to hypoxia present an 
increase in GFAP levels. It has been also shown that this tissue presents astrogliosis after 
hypoxia-ischemia in a rodent model [32]. As expected, we observed a higher number of 
GFAP-positive cells in the striatum of asphyctic animals (see Fig. 1). This was not 
accompanied by neuronal loss as previously reported [6]. 
The damage cause in the striatum may cause behavioral changes. Laviola et al. [33] has 
suggested that changes in the rodent striatum may be related to susceptibility to stereotyped 
behavior and irregular reactions to social and environmental novelty. Moreover, damage in 
the striatum caused by perinatal asphyxia is associated with deficits in motor performance 
[34]. 
4.2. Perinatal asphyxia is associated with a reduced expression of NAPE-PLD and 
PPARα 
In the present work, we were able to observe a reduction in the expression of NAPE-PLD 
and PPARα in the striatum (Figs. 2 and 3), similarly to what we have previously reported in 
the hippocampus [35]. Since NAPE-PLD is responsible for the production of AEs, these 
and previous results lead us to hypothesize that the levels of the endocannabinoid AEA and 
other non-cannabinoid lipids, such as OEA and PEA, suffer a decrease in hippocampus and 
dorsal striatum following PA. Moreover, the lack of differences in FAAH levels (Fig. 4) 
could indicate that AEs degradation is stable in all groups. These results discard the 
possibility that a NAPE-PLD decrement could be compensated by a change in the 
degradation through FAAH, and gives more evidence to the hypothesis that NAPE-PLD 
changes are coupled to changes in AEs. Regarding the reduction in PPARα expression, this 
finding leads our attention toward its ligands, OEA and PEA, since it has been shown that 
PPARα plays a key role in the neuroprotective effect that non-cannabinoid AEs present 
after an ischemic event [27,28]. O’ Sullivan et al. [36] and Sun et al. [37] have shown that 
OEA, not only bounds to PPARα, but that it also positively regulates its transcriptional 
activity. Thus a decrease in OEA production may induce a reduction in PPARα. These 
results may indicate that the production and actions of AEs that present no 
endocannabinoid activity are affected due to PA in the striatum, which holds relevance due 
to the fact that OEA and PEA present neuroprotective effects in cerebral ischemia [27,28]. 
Furthermore, DAGLα was increased in the C+ group (see Fig. 2). We can not draw a 
conclusion about the role that this enzyme plays in cesarean delivery and further studies are 
needed to address this issue properly, however, a previous work has shown that there is an 
increase in different AEs in newborns delivered by C-section compared to vaginal delivery, 
while there are no changes in 2-AG concentrations [38]. Thus, the increase in DAGLα 
levels may be related to the maintenance of 2-AG levels. 
Regarding the changes in CB1 expression, these should be interpreted taking into account 
that this receptor may be involved in matters such as female reproduction [39]. In this 
work, we observed an increase in CB1 expression in the PA group compared to the CTL 
group, however there were no differences between PA and C+ groups. Indeed, these 
changes may be occurring due to the effect of the cesarean procedure to which these 
animals are subjected in the present experimental model. Animals subjected to C-section 
presented higher levels of CB1 than the control ones, while those that were exposed to 
asphyxia showed an increase compared to the C+ animals. Nevertheless, these changes 
were not significant. However, they can contribute to the significant change observed 
between the AP and CTL groups. In order to study these changes more closely further 
experiments focusing on cesarean birth should be carried out. 
5. Conclusions 
In the present work, we have observed a reduced expression of NAPE-PLD and PPARα in 
striatum of asphyctic animals. These reductions were accompanied by astrogliosis without 
neuronal loss. Overall, these results may indicate a dysregulation of the signaling pathway 
of non-cannabinoid AEs in the striatum of postweaned asphyctic rats and encourage us 
toward conducting future studies in order to determine the potential neuroprotective effects 
of AEs in animal models of PA. 
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Figure legends 
Fig 1. GFAP immunostaining is increased in dorsal striatum of perinatally asphyctic 
rats. (A) Representative photomicrographs showing NeuN-positive cells (upper panel) and 
GFAP-positive cells (lower panel) in dorsal striatum. Scale bars = 30 µm (insets: 5 µm). Red 
arrows indicate astrocytes. (B) Quantification of the number of total NeuN-positive cells (left 
panel) and GFAP-positive cells per mm2 (right panel). No changes in the total number of 
NeuN+ cells are observed while the number of GFAP+ cells is increased in the PA group. 
Bars show the mean + SEM. *p < 0.05 vs. CTL; #p < 0.05 vs. C+. 
Fig. 2. Effects of cesarean section and perinatal asphyxia on DAGLα and NAPE-PLD 
expression in dorsal striatum. (A) Representative photomicrographs showing DAGLα 
(upper panel) and NAPE-PLD (lower panel) immunostaining in dorsal striatum. Scale bars 
= 75 µm. (B) Densitometric quantification of DAGLα (left panel) and NAPE-PLD (right 
panel) immunostaining. In the C+ group DAGLα expression is increased, while NAPE-PLD 
immunostaining is reduced in the PA group. Bars show the mean + SEM. *p < 0.05 vs. CTL; 
#p < 0.05 vs. C+; &p < 0.05 vs. PA. 
Fig. 3. Effects of perinatal asphyxia on CB1 and PPARα expression in dorsal striatum. 
(A) Representative photomicrographs showing CB1 (upper panel) and PPARα (lower panel) 
immunostaining in dorsal striatum. In the upper panel the medial and lateral dorsal striatum 
are delimited. Scale bars = 30 µm (insets: 5 µm). (B) Densitometric quantification of the CB1 
immunostaining (left panel) and the number of PPARα-positive nuclei per mm2. CB1 
immunostaining is increased in the PA group compared only to the CTL group, both in lateral 
and medial subregions, while the number of PPARα+ nuclei per mm2 is decreased in the PA 
group compared to the other two groups. Bars show the mean + SEM. *p < 0.05 vs. CTL; ##p 
< 0.01 vs. C+. 
Fig. 4. Immunohistochemical expression of FAAH in dorsal striatum. (A) Representative 
photomicrographs showing FAAH immunostaining in dorsal striatum, Scale bars = 30 µm. 
(B) Densitometric quantification of the FAAH immunostaining. No changes are observed in 
FAAH expression between the groups. Bars show the mean + SEM. 
Fig. 5. Schematic summary of the effects that PA exerts over the ECS and AEs. AEs and 
MAGs are produced in neurons through the action of NAPE-PLD (red) and DAGLα (green) 
respectively. AEs, such as AEA, bind to CB1 (blue) receptors while others such as OEA bind 
to PPARα (yellow) and elicit a number of different cellular responses. AEs are degraded 
through the action of FAAH (purple) in neurons. After a PA event (bright red) levels of 
NAPE-PLD are decreased, probably leading to a lower production of AEs. Since the 
transcription of PPARα is in part regulated by OEA, lower levels of this AE may also be 
causing a decrease of PPARα. 
AEA: arachidonoylethanolamide 
AEs: acylethanolamides 
CB1: cannabinoid receptor 1 
CB2: cannabinoid receptor 2 
DAGL: diacylglycerol lipase 
eCBs: endocannabinoids 
ECS: endogenous cannabinoid system 
FAAH: fatty acid amide hydrolase 
MAGL: MAG lipase 
MAGs: monoacylglycerols 
NAPE: N-acyl-phosphatidylethanolamine  
NAPE‐PLD: NAPE‐hydrolyzing phospholipase D 
OEA: oleoylethanolamide 
PA: Perinatal asphyxia 
PEA: palmitoylethanolamide 
PPARα:  peroxisome proliferator-activated receptor alpha 
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